Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.9000
+0.2000
+(28.57%)
At close: 3:09:43 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
16,751
1,202
-494
-49,137.0460
-50,497.2700
Investing Cash Flow
--
15,121
-37
-10,107.5160
-14.7400
Financing Cash Flow
-7,897
-8,516
1,497
470
14
End Cash Position
10,005
8,772
966
29,620.7060
77,524.3230
Capital Expenditure
--
--
-37
--
--
Issuance of Capital Stock
7,134
6,464
1,497
470
14
Issuance of Debt
--
--
14,979.7600
--
--
Repayment of Debt
-14,980
-14,980
--
--
--
Free Cash Flow
16,751
1,202
-531
-49,137.0460
-50,497.2700
12/31/2020 - 3/9/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MAGLE.ST Magle Chemoswed Holding AB (publ)
32.40
0.00%
NV3P.F NanoViricides, Inc.
1.1300
-11.72%
MOC.WA Molecure S.A.
9.00
+1.69%
RGO.DU Regeneron Pharmaceuticals Inc
684.00
+1.33%
HQ1.MU Oruka Therapeutics Inc. R
10.30
-2.83%
BSSP Baseline Productions, Inc.
0.0001
0.00%
PH4.F CStone Pharmaceuticals
0.4320
+1.89%
GYX.F Futura Medical plc
0.1340
-25.56%
BXPHF Botanix Pharmaceuticals Limited
0.2950
0.00%
10VA.F Immunic, Inc.
1.1000
-1.79%